Heidi Health, a Melbourne, Australia-based healthcare AI scribe company, raised USD $16.6M in Series A follow-on funding round.
The round was led by Headline, with participation from Local Globe, Anthology (Menlo Ventures and Anthropic) and existing investors Blackbird, HESTA, Possible Ventures and Archangel Ventures.
The company intends to use the funds to enhance functionality, which will include creating pre-chart summaries, accessing clinical guidelines for treatments and management pathways, and engaging with patients outside the clinic.
Led by Dr Thomas Kelly, CEO and co-founder, Heidi provides a personalised and customisable AI scribe. Heidi works effectively in a variety of busy clinical environments – from emergency departments to surgical theatres. The scribe operates in the background, does not store session recordings and is fully compliant with region-specific privacy and data security regulations across the globe, meaning it can safely be used in all practice settings.
Since launching in February 2024, Heidi’s AI scribe has supported clinicians in over 20 million patient interactions globally.
FinSMEs
07/03/2025